Select Topics Flashcards
What is pharmacogenetics?
The individual impact on drug efficacy and toxicity. Genetics dictate enzyme differences across and within species.
What are the observable differences in human pharmacogenetics?
Enzyme effectiveness
DDIs
Drug toxicity
What are DMEs exhibiting polymorphisms?
CYP2D6 CYP2C9 CYP2C19 UDP-Glucuronosyl Transferase (UGT 1A1) NAT2 Thipurine S-MEthyltransferase (TPMT)
What is the consequence of being a CYP2C19 poor metabolizer in the different subpopulations when Mephenytoin is given?
3 Phenotypes(EM, IM, PM) 3-5% Caucasians 12-23% Asians 3% African Americans are poor metabolizers and thus have sedation when given Mephenytoin.
What subpopulations does CYP2D6 have?
PM-poor metabolizers
IM-intermediate metabolizers
EM-extensive metabolizers
UM-ultra-rapid metabolizers
What phenotypic subpopulations does NAT2 have?
Rapid acetylators (Eskimos) Slow acetylators (Egyptians) affects Isoniazid
What are NAT2 slow acetylators associated with?
10-20% decrease in enzyme amounts in liver cytosol and decrease in NAT2 enzyme activity.
When was the Human Genome Project Established?
1990
When was the emergence of pharmacogenomics?
1995
What is pharmacogenomics?
It involves the genome-wide anaylsis of genetic determinants of drug efficacy and toxicity.
Requires genetic profiling and advocates genetically guided therapy.
Used in chemotherapy.
What is the ultimate goal of pharmacogenomics?
Tailored, personalized, individualized drug therapy.
What is polymorphism?
Variations in DNA nucleotide sequences
What are the types of polymorphism?
Single nucleotide (A,T,C,G) polymorphism (SNP) >1 nucleotide changes Entire gene insertion Entire gene deletion Extra gene copies
What are the effects of polymorphism?
Lead to disease
Alter protein function (DME)
Ultimately drug therapeutic efficacy is impacted.
Which enzyme has 80 plus different alleles?
CYP2D6
What is important about CYP2D6*5?
It has deleted nucleotide base pairs in the 2D6 gene
Not a SNP
Results in loss of CYP2D6 function which makes it a poor metabolizer phenotype.
What drugs does CYP2D6*5 affect?
Metoprolol, SSRIs, codeine, atomoxetine, tamoxifen, etc. (MS.CAT)